scorecardresearch
Add as a preferred source on Google
Wednesday, September 24, 2025
TopicDrug makers

Topic: Drug makers

‘Does govt have the resources?’ Why pre-export testing of cough syrups may not plug all loopholes

Govt has made sample testing of cough syrups a must before export. Pharmaceutical analysts say this is a good move, but it may not be able to address all issues in drug quality management.

China targeting India? Import costs of paracetamol, antibiotics ingredients see 100% jump

Experts believe hiking prices could be Chinese response to the Modi government’s Profit Linked Incentive scheme, which seeks to achieve self-dependence in API production.

Mankind Pharma, Intas found selling diabetes drug ‘without nod’, to get show cause notice

Delhi-based Mankind Pharma & Gujarat's Intas Pharmaceuticals sold a Type 2 diabetes drug without seeking price approval from National Pharmaceutical Pricing Authority.

Watchdog on pharma ethics violations says it has no such power in RTI reply, takes U-turn later

NPPA has been seeking reports from industry bodies on complaints regarding violations of the self-regulatory mechanism meant to discourage pharma malpractices. But it said in reply to an RTI query that this isn't part of its mandate. 

Drugmakers want Modi govt to defer revision of essential medicines list, cite Covid crisis

Drugmakers have also requested the government to consider ‘essentiality’ of the drug, and not its ‘turnover’, as the criterion for inclusion under NLEM.

Remdesivir maker Gilead to expand production of drug most sought-after for Covid treatment

Gilead Sciences plans a global consortium of pharma firms for production. It says decision of partnership will depend on how fast the drug’s supply can be ramped up.

Stock of insulin, cardiac drugs dips ‘below normal’ levels as India panic buys in lockdown

States and union territories have been instructed to ensure production and supply of cardiac and anti-diabetic medicines, including insulin.

Azithromycin, paracetamol, other APIs see upto 190% price jump as China resumes production

Antibiotics azithromycin and ornidazole, anti-inflammatory drug nimesulide and antipyretic drug paracetamol have seen prices surge between 60 and 190%.

Govt to fly raw material from coronavirus-hit China for Cipla as shortage fears continue

There are fears that supply of essential medicines — including for HIV & cancer — may dwindle if supply chains in coronavirus-hit China don’t normalise soon. 

India’s price control policy has destroyed drug manufacturers. This is how they can be saved

India has one of the lowest drug prices in the world, yet many Indians are deprived of life-saving drugs. Price controls haven't been enough to bridge this gap.

On Camera

‘I am Assam,’ Zubeen Garg had said. He was the soundtrack to our lives

Zubeen Garg's funeral entered the Limca Book of Records as the fourth-largest such procession in the world.

Market regulator SEBI clears Adani Group of impropriety alleged by Hindenburg Research

SEBI probe concluded that purported loans and fund transfers were paid back in full and did not amount to deceptive market practices or unreported related party transactions.

China navy achieves breakthrough with new fighter jet launch system. What are electromagnetic catapults

China’s most advanced aircraft carrier—Fujian—uses electromagnetic catapults, a core component of future aircraft carriers.

India doesn’t give walkovers to Pakistan in war. Here’s why it shouldn’t do it in cricket either

Many really smart people now share the position that playing cricket with Pakistan is politically, strategically and morally wrong. It is just a poor appreciation of competitive sport.